Advertisement
ABCL vs CAI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and CAI is a Hold.
ABCL sees its Stochastic Oscillator ascending out of oversold territory
On November 05, 2026, the Stochastic Oscillator for ABCL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 65 instances where the indicator left the oversold zone. In 53 of the 65 cases the stock moved higher in the following days. This puts the odds of a move higher at over 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +12.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCL advanced for three days, in 207 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABCL as a result. In 78 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for ABCL turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 35 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
ABCL moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ABCL crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
ABCL broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ABCL entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.296) is normal, around the industry mean (3.498). P/E Ratio (-22.000) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
CAI's RSI Oscillator remains in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAI advanced for three days, in 46 of 67 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
CAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CAI as a result. In 23 of 28 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for CAI turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In 9 of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CAI moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CAI crossed bearishly below the 50-day moving average on November 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. CAI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.049) is normal, around the industry mean (3.498). P/E Ratio (2.634) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (9.059). Dividend Yield (0.021) settles around the average of (130.981) among similar stocks. P/S Ratio (8.084) is also within normal values, averaging (440.869).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ABCL | CAI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 46 | |
PRICE GROWTH RATING 1..100 | 34 | 47 | |
P/E GROWTH RATING 1..100 | 98 | 8 | |
SEASONALITY SCORE 1..100 | 50 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABCL's Valuation (9) in the null industry is significantly better than the same rating for CAI (84) in the Finance Or Rental Or Leasing industry. This means that ABCL’s stock grew significantly faster than CAI’s over the last 12 months.
ABCL's Profit vs Risk Rating (100) in the null industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that ABCL’s stock grew similarly to CAI’s over the last 12 months.
CAI's SMR Rating (46) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for ABCL (94) in the null industry. This means that CAI’s stock grew somewhat faster than ABCL’s over the last 12 months.
ABCL's Price Growth Rating (34) in the null industry is in the same range as CAI (47) in the Finance Or Rental Or Leasing industry. This means that ABCL’s stock grew similarly to CAI’s over the last 12 months.
CAI's P/E Growth Rating (8) in the Finance Or Rental Or Leasing industry is significantly better than the same rating for ABCL (98) in the null industry. This means that CAI’s stock grew significantly faster than ABCL’s over the last 12 months.
| ABCL | CAI | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 87% | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 71% |
| Advances ODDS (%) | 3 days ago 81% | 8 days ago 69% |
| Declines ODDS (%) | 1 day ago 82% | 6 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 83% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABCL’s FA Score shows that 1 FA rating(s) are green while CAI’s FA Score has 1 green FA rating(s).
- ABCL’s FA Score: 1 green, 4 red.
- CAI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABCL’s TA Score shows that 2 TA indicator(s) are bullish while CAI’s TA Score has 4 bullish TA indicator(s).
- ABCL’s TA Score: 2 bullish, 7 bearish.
- CAI’s TA Score: 4 bullish, 5 bearish.
Price Growth
ABCL (@Biotechnology) experienced а -2.69% price change this week, while CAI (@Biotechnology) price change was -26.28% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.
Reported Earning Dates
ABCL is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Biotechnology (-0.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ABCL and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with ABSI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then ABSI could also see price increases.
| Ticker / NAME | Correlation To ABCL | 1D Price Change % | ||
|---|---|---|---|---|
| ABCL | 100% | -4.09% | ||
| ABSI - ABCL | 57% Loosely correlated | +1.50% | ||
| RXRX - ABCL | 57% Loosely correlated | +1.13% | ||
| VCYT - ABCL | 56% Loosely correlated | +4.36% | ||
| CRSP - ABCL | 55% Loosely correlated | +1.33% | ||
| NTLA - ABCL | 55% Loosely correlated | +2.15% | ||
More | ||||
CAI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CAI has been loosely correlated with TWST. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then TWST could also see price increases.
| Ticker / NAME | Correlation To CAI | 1D Price Change % | ||
|---|---|---|---|---|
| CAI | 100% | +0.25% | ||
| TWST - CAI | 45% Loosely correlated | -7.22% | ||
| RXRX - CAI | 42% Loosely correlated | +1.13% | ||
| BMEA - CAI | 38% Loosely correlated | +11.68% | ||
| ABCL - CAI | 38% Loosely correlated | -4.09% | ||
| ABSI - CAI | 36% Loosely correlated | +1.50% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QDF | 90.75 | 1.03 | +1.15% |
| Northern Trust Quality Dividend ETF (QDF) | |||
| BCLO | 49.29 | 0.03 | +0.06% |
| iShares BBB-B CLO Active ETF (BCLO) | |||
| FRA | 10.29 | -0.04 | -0.39% |
| Blackrock Floating Rate Income Strategies Fund | |||
| TSMZ | 7.71 | -0.33 | -4.08% |
| Direxion Daily TSM Bear 1X ETF (TSMZ) | |||
| TSDD | 6.14 | -0.36 | -5.54% |
| GraniteShares 2x Short TSLA Daily ETF (TSDD) | |||